The use of gene transfer technology to study the pathophysiology of erectile dysfunction

被引:9
作者
Bivalacqua, Trinity J. [1 ]
Strong, Travis D. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA
关键词
nitric oxide; gene therapy; phosphodiesterase type-5; endothelium; nitric oxide synthase;
D O I
10.1111/j.1743-6109.2007.00758.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The past 2 5 years of basic science research on erectile physiology has been devoted to investigating the pathogenesis of erectile dysfunction. Research has led to a better understanding of the biochemical factors and intracellular mechanisms responsible for corporal smooth muscle contraction and relaxation, as well as the influence of endothelial-derived relaxing factors. Aim. In this essay, we propose the use of gene transfer technology study mechanisms of disease involved in penile vascular dysfunction. Methods. The development of methods to deliver therapeutic genes to the penis has kindled a keen interest in treating ED with gene- and cell-based therapies. Results. Gene therapy has delineated putative mechanisms of disease in animal models of erectile dysfunction. Conclusion. Investigation of animal models using gene therapy may ultimately lead to mechanism-based therapies for the treatment of erectile dysfunction.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 19 条
[1]   Endothelial nitric oxide synthase gene therapy for erectile dysfunction [J].
Bivalacqua, TJ ;
Musicki, B ;
Usta, MF ;
Champion, HC ;
Kadowitz, PJ ;
Burnett, AL ;
Hellstrom, WJG .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (31) :4059-4067
[2]   RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction [J].
Bivalacqua, TJ ;
Champion, HC ;
Usta, MF ;
Cellek, S ;
Chitaley, K ;
Webb, RC ;
Lewis, RL ;
Mills, TM ;
Hellstrom, WJG ;
Kadowitz, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9121-9126
[3]   Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis [J].
Bivalacqua, Trinity J. ;
Liu, Tongyun ;
Musicki, Bijana ;
Champion, Hunter C. ;
Burnett, Arthur L. .
EUROPEAN UROLOGY, 2007, 51 (06) :1732-1740
[4]   Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase [J].
Bivalacqua, Trinity J. ;
Burnett, Arthur L. ;
Hellstrom, Wayne J. G. ;
Champion, Hunter C. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (03) :H1340-H1351
[5]   Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism [J].
Champion, HC ;
Bivalacqua, TJ ;
Takimoto, E ;
Kass, DA ;
Burnett, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (05) :1661-1666
[6]   Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function [J].
Christ, GJ ;
Rehman, J ;
Day, N ;
Salkoff, L ;
Valcic, M ;
Melman, A ;
Geliebter, J .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (02) :H600-H608
[7]   Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo [J].
Christ, GJ ;
Day, N ;
Santizo, C ;
Sato, YS ;
Zhao, WX ;
Sclafani, T ;
Bakal, R ;
Salman, M ;
Davies, K ;
Melman, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (04) :H1544-H1553
[8]   Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats [J].
Häggström, S ;
Lissbrant, IF ;
Bergh, A ;
Damber, JE .
JOURNAL OF UROLOGY, 1999, 161 (05) :1620-1625
[9]   Gene therapy for erectile dysfunction: Fact or fiction? [J].
Kendirci, Muammer ;
Teloken, Patrick E. ;
Champion, Hunter C. ;
Hellstrom, Wayne J. G. ;
Bivalacqua, Trinity J. .
EUROPEAN UROLOGY, 2006, 50 (06) :1208-1222
[10]  
Lavigne Matthieu D, 2006, Expert Opin Emerg Drugs, V11, P541, DOI 10.1517/14728214.11.3.541